Indivior Pharmaceuticals Inc (INDV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2017 | 06-2017 | 03-2017 | 12-2016 | 09-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 806,000 | 792,000 | 729,000 | 692,000 | 586,000 |
| Receivables | 277,000 | 272,000 | 258,000 | 257,000 | 242,000 |
| Inventories | 51,000 | 49,000 | 47,000 | 41,000 | 48,000 |
| TOTAL | $1,134,000 | $1,113,000 | $1,034,000 | $990,000 | $876,000 |
| Non-Current Assets | |||||
| PPE Net | 49,000 | 43,000 | 34,000 | 27,000 | 53,000 |
| Intangibles | 94,000 | 82,000 | 82,000 | 83,000 | 48,000 |
| Other Non-Current Assets | 90,000 | 91,000 | 75,000 | 109,000 | 112,000 |
| TOTAL | $233,000 | $216,000 | $191,000 | $219,000 | $213,000 |
| Total Assets | $1,367,000 | $1,329,000 | $1,225,000 | $1,209,000 | $1,089,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 129,000 | 129,000 | 101,000 | 101,000 | 55,000 |
| Accounts payable and accrued liabilities | 630,000 | 603,000 | 602,000 | 658,000 | 593,000 |
| Other current liabilities | 219,000 | 242,000 | 218,000 | 219,000 | 220,000 |
| TOTAL | $1,058,000 | $1,069,000 | $973,000 | $1,030,000 | $938,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 341,000 | 352,000 | 423,000 | 434,000 | 491,000 |
| Other Non-Current Liabilities | 42,000 | 41,000 | 40,000 | 40,000 | 42,000 |
| TOTAL | $383,000 | $393,000 | $463,000 | $474,000 | $533,000 |
| Total Liabilities | $1,441,000 | $1,462,000 | $1,436,000 | $1,504,000 | $1,471,000 |
| Shareholders' Equity | |||||
| Common Shares | 72,000 | 72,000 | 72,000 | 72,000 | 72,000 |
| Retained earnings | 1,163,000 | 1,108,000 | 1,032,000 | 950,000 | 861,000 |
| Other shareholders' equity | -1,311,000 | -1,314,000 | -1,315,000 | -1,317,000 | -1,315,000 |
| TOTAL | $-74,000 | $-133,000 | $-211,000 | $-295,000 | $-382,000 |
| Total Liabilities And Equity | $1,367,000 | $1,329,000 | $1,225,000 | $1,209,000 | $1,089,000 |